Cargando…
The Addition of Other Fecal Biomarkers Does Not Improve the Diagnostic Accuracy of Immunochemical Fecal Occult Blood Test Alone in a Colorrectal Cancer Screening Cohort
Background: Screening with fecal occult blood test reduces colorectal cancer (CRC) incidence and mortality, and is currently implemented in most countries. However, around 40% of screening colonoscopies are normal. Thus, strategies to avoid these colonoscopies are highly necessary. Adding other feca...
Autores principales: | Hijos-Mallada, Gonzalo, Lué, Alberto, Velamazan, Raul, Saura, Nuria, Abril, Carlos, Lorenzo, Marta, Navarro, Mercedes, Chueca, Eduardo, Arechavaleta, Samantha, Gomollón, Fernando, Lanas, Ángel, Sostres, Carlos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212973/ https://www.ncbi.nlm.nih.gov/pubmed/34150803 http://dx.doi.org/10.3389/fmed.2021.665786 |
Ejemplares similares
-
A Patient Self-Made Point-of-Care Fecal Test Improves Diagnostic Accuracy Compared with Fecal Calprotectin Alone in Inflammatory Bowel Disease Patients
por: Hijos-Mallada, Gonzalo, et al.
Publicado: (2021) -
A Point-of-Care Faecal Test Combining Four Biomarkers Allows Avoidance of Normal Colonoscopies and Prioritizes Symptomatic Patients with a High Risk of Colorectal Cancer
por: Hijos-Mallada, Gonzalo, et al.
Publicado: (2023) -
Reducing the Cut-Off Value of the Fecal Immunochemical Test for Symptomatic Patients Does Not Improve Diagnostic Performance
por: Navarro, Mercedes, et al.
Publicado: (2020) -
The combination of quantitative faecal occult blood test and faecal calprotectin is a cost-effective strategy to avoid colonoscopies in symptomatic patients without relevant pathology
por: Lué, Alberto, et al.
Publicado: (2020) -
Screening for Colorectal Cancer by Immunochemical Fecal Occult Blood Testing
por: Saito, Hiroshi
Publicado: (1996)